This is not the most recent version of the article. View current version (21 NOV 2014)

Intervention Protocol

Lipid lowering efficacy of rosuvastatin

  1. Stephen P Adams,
  2. James M Wright*

Editorial Group: Cochrane Heart Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD010254


How to Cite

Adams SP, Wright JM. Lipid lowering efficacy of rosuvastatin (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010254. DOI: 10.1002/14651858.CD010254.

Author Information

  1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada

*James M Wright, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Medical Block C, Vancouver, V6T 1Z3, Canada. jim.wright@ti.ubc.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

This is not the most recent version of the article. View current version (21 NOV 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objective

To quantify the effects of various doses of rosuvastatin on serum total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides in subjects with and without evidence of cardiovascular disease. The primary focus of the review will be on the mean per cent change of LDL-cholesterol.

Secondary objective

To quantify the variability of the effect of various doses of rosuvastatin.

To quantify withdrawals due to adverse effects in the randomized placebo controlled trials.